Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Wei-Wei Peng
Ying Liu
Huan-Huan Sha
Shao-Di Wen
Ying Fang
Guo-Ren Zhou
机构：
[1] Jiangsu Institute of Cancer Research,Jiangsu Cancer Hospital
[2] The Affiliated Cancer Hospital of Nanjing Medical University,undefined
来源：
BMC Pulmonary Medicine | / 23卷
关键词：
Non-small cell lung cancer (NSCLC); Plasma cell-free DNA (cfDNA); Prognosis biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer
    Peng, Wei-Wei
    Liu, Ying
    Sha, Huan-Huan
    Wen, Shao-Di
    Fang, Ying
    Zhou, Guo-Ren
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [2] Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer
    Nie, Kun
    Jia, Yujie
    Zhang, Xuezhu
    TUMOR BIOLOGY, 2015, 36 (01) : 7 - 19
  • [3] Cell-free DNA concentration as a prognostic biomarker in patients with non-small cell lung cancer under immunotherapy treatment
    Barragan, Isabel
    Perez-Ruiz, Elisabeth
    Onieva, Juan Luis
    Garrido-Ramos, Maria
    Martinez-Galvez, Beatriz
    Dubbelman, Jaime
    Alba, Emilio
    Zafra, Juan
    Cobo, Manuel
    Oliver, Javier
    Rueda-Dominguez, Antonio
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Correlation between cell-free DNA and survival in patients receiving Nivolumab for advanced non-small cell lung cancer
    Rijavec, E.
    Biello, F.
    Alama, A.
    Dal Bello, M. G.
    Coco, S.
    Vanni, I.
    Genova, C.
    Barletta, G.
    Rossi, G.
    Maggioni, C.
    Gaitan, N. S. D.
    Distefano, R.
    Tagliamento, M.
    Merlo, D. F.
    Grossi, F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 160 - 160
  • [5] Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
    Ai, Bo
    Liu, Huiquan
    Huang, Yu
    Peng, Ping
    ONCOTARGET, 2016, 7 (28) : 44583 - 44595
  • [6] The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
    Maria Gabriela O. Fernandes
    Natália Cruz-Martins
    José Carlos Machado
    José Luís Costa
    Venceslau Hespanhol
    Cancer Cell International, 21
  • [7] The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
    Fernandes, Maria Gabriela O.
    Cruz-Martins, Natalia
    Machado, Jose Carlos
    Costa, Jose Luis
    Hespanhol, Venceslau
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [8] Cell-free circulating tumour DNA (ctDNA) in the management of patients with non-biopsiable advanced non-small cell lung cancer (NSCLC)
    Kushnir, M.
    Winter, H.
    Murias, C.
    Bains, P.
    Abbosh, C. Z.
    Papadatos-Pastos, D.
    Newsome-Davis, T.
    Ahmed, T.
    Swanton, C.
    Forster, M. D.
    Moore, D.
    Bennett, P.
    Faull, I.
    Lanman, R. B.
    Arkenau, H-T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Predictive factors for detectability of genomic alterations from circulating cell-free DNA in patients with advanced non-small cell lung cancer
    Kimura, H.
    Koba, H.
    Kasahara, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Epigenomic Mapping of Cell-Free DNA in Patients with Non-Small Cell Lung Cancer
    Bestvina, C.
    Karpus, J.
    Cui, X.
    Oosterbaan, C.
    Won, B.
    He, C.
    Patel, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S432 - S433
12345